Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSS0393 Ointment in Plaque Psoriasis
NCT07543224Phase 3Not yet recruiting
- Sponsor
- Reistone Biopharma
- Start
- Apr 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of RSS0393 in plaque psoriasis, sponsored by Reistone Biopharma. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
RSS0393
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07543224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07543224.